An interventional study of Virtual Reality-based Mirror Therapy (VR+MT) and Mixed Reality-based Mirror Therapy (MR+MT) in Stroke, Cerebrovascular Disorders and Central Nervous System Diseases, sponsored by Chang Gung Memorial Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 88 studies in Stroke by Chang Gung Memorial Hospital — 13 open to participants now, 13 under way, none of them phase 3. Stroke · Chang Gung Memorial Hospital.
Among the 88 studies in Stroke by Chang Gung Memorial Hospital, this one is the 45th largest by planned enrollment of the 82 interventional ones that give a count, is one of 3 that started in 2024, is one of 71 with no phase, reaches primary completion later than 6 of the 12 other live ones, and was the 77th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →13 of the 88 studies in Stroke by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–80
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20+ · Healthy volunteers
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 40–80
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 18–75
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–75
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 20 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
88 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 6
First in 2007; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 45 is close to the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 55 across the 82 interventional studies, 120 across the 6 observational. Of the 49 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.
5 of the studies in Stroke by Chang Gung Memorial Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06204744Chang Gung Memorial HospitalHome-based Arm and Hand Exercise Program for Stroke: A Multisite Trial | 2026-12 |
| NCT06258538Chang Gung Memorial HospitalEffects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke | 2026-12-31 |
| NCT05238272Chang Gung Memorial HospitalNovel Brain Neurotechnology for Optimizing Precision Mirror Therapy in Stroke | 2026-12-31 |
| NCT05903235Chang Gung Memorial HospitalMixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation | 2027-07-31 |
| NCT07054424Chang Gung Memorial HospitalRepetitive Transcranial Magnetic Stimulation Combined With Bimanual Therapy for Upper Limb Stroke Rehabilitation | 2027-07-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 88 studies in Stroke by Chang Gung Memorial Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The specific study aims will be:
Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study
Sixteen patients with stroke will be recruited in this phase Ⅰ study. During the pilot testing, each stroke patient will use each of the VR+MT and MR+MT systems with the assistance of a researcher holding the occupational therapist certification. The order of the feasibility test of the 2 systems will be counterbalanced across the patients. At the end of the feasibility study of each system, the patients will be asked to complete the System Usability Scale, Virtual Reality Sickness Questionnaire, and a self-designed questionnaire to assess the user experience and perspective about these new systems and their view of its suitability for stroke patients.
Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy
This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of VR+MT, MR+MT, and traditional MT. An estimated 45 patients with stroke will be recruited to participate in this phase Ⅱ study. Each participant will receive a total of 15 training sessions (40 minutes per session) within 5 weeks. Clinical outcome measures will be conducted at baseline, at immediately after treatment, and at 1 month follow-up after treatment.
Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems \& Feasibility Study
Inclusion Criteria:
Exclusion Criteria:
Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy
Inclusion Criteria:
Exclusion Criteria:
In each therapy session, the patients will execute 2 upper-limb functional tasks, starting with easy then more complex tasks.
Behavioral: Virtual Reality-based Mirror Therapy (VR+MT)
The patients will execute 2 upper-limb functional tasks in each session.
Behavioral: Mixed Reality-based Mirror Therapy (MR+MT)
The patients will execute 2 to 3 categories of activities per training session: (1) active range of motion exercises, (2) reaching movement or object manipulation, and (3) upper-limb functional tasks.
Behavioral: Traditional Mirror Therapy (MT)
In this VR+MT group, the patients will be instructed to perform the unilateral movements of the non-affected upper limb simultaneously while observing the animated hand as mirroring reflection of the affected hand within the immersive environment, which presented on the goggle via the VR+MT system.
In the MR+MT group, the patients will be instructed to perform the unilateral movements of the non-affected upper limb concurrently meanwhile watching the real-time mirroring image reflection of the non-affected upper limb's movements of the patients captured, transformed, and superimposed on the affected upper limb, which projected to the screen from the front side via the MR+MT system.
In the traditional MT group, patients will be instructed to perform the unilateral movements of the non-affected upper limb at the same time while watching the mirror of a mirror box placed in front of the patient's midsagittal plane, in which the illusory reflection of the non-affected upper limb appears as if it were the another affected upper limb.
Change scores of Fugl-Meyer Assessment of the Upper Extremity
The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a measure with sound psychometric properties to evaluate upper-limb hemiparesis of patients following stroke. The total, proximal and distal scores of the FMA-UE range from 0 to 66, from 0 to 42, and from 0 to 24, respectively; a higher score indicates better upper-limb motor function.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of Nottingham Extended Activities of Daily Living scale
The Nottingham Extended Activities of Daily Living scale is an ease-of-use measure with sound reliability and validity to assess independence of more complex daily function. Each item scores ranged from 0 (no/unable) to 3 (on my own/able) with a total score range of 0 to 66. A higher score indicates greater independence of instrumental activities of daily living.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of grip strengths
The Jamar® Plus+ Digital Hand Dynamometer has been designed similarly to the reliable and validated Jamar Hydraulic Hand Dynamometer to measure the grip strength. The grip strengths of both hands were alternatively measured in kilograms (kg) by adopting the average of three measurements.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of lateral pinch strengths
The Jamar® Plus+ Digital Pinch Gauge has been developed and widely used with the advantages of an easy-to-read digital readout and being capable of storing data. The lateral pinch strengths of both hands will be alternatively measured in kilograms (kg) by adopting the average of three measurements.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of palmar pinch strengths
The Jamar® Plus+ Digital Pinch Gauge has been developed and widely used with the advantages of an easy-to-read digital readout and being capable of storing data. The palmar pinch strengths of both hands will be alternatively measured in kilograms (kg) by adopting the average of three measurements.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of Box and Block Test
The Box and Block Test (BBT) is a tool with sound reliability and validity to evaluate hand dexterity. The number of cubes moved represents the BBT score, with a higher score indicating better gross dexterity.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of Revised Nottingham Sensory Assessment
The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to evaluate sensory function of patients following stroke. The scores of the tactile sensation, proprioception, and stereognosis subscales range from 0 to 108, from 0 to 21, and from 0 to 22, respectively; a higher score indicates better somatosensory function.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of Chedoke Arm and Hand Activity Inventory
The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to evaluate the independence of patients following stroke to perform activities of daily living with an affected upper limb. Each task scores ranged from 1 (total assist) to 7 (complete independence) with a total score range of 13 to 91. A higher score indicates greater recovery of arm and hand function.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of the health state of EQ-5D-5L
The questionnaire of EQ-5D-5L comprises 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5-dimension questionnaire represents the health state.
Time frame: baseline, 5 weeks, 9 weeks
Change scores of the visual analogue scale of EQ-5D-5L
The visual analogue scale of EQ-5D-5L score will be scored from 0 to 100. A higher score indicates better overall current health.
Time frame: baseline, 5 weeks, 9 weeks
Started Mar 2024 (actual). Primary completion is estimated for Jul 2027, 40 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 40 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: primary completion Jul 2026 → Jul 2027 and completion Jul 2026 → Jul 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital →